Patents by Inventor Jonathan Steven Sammon

Jonathan Steven Sammon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11926642
    Abstract: The invention relates to compounds of formula I wherein R1, R2 and - - - - - are as defined herein, pharmaceutical compositions comprising the compounds and methods of treating COVID-19 in a patient by administering therapeutically effective amounts of the compounds and methods of inhibiting or preventing replication of SARS-CoV-2 with the compounds.
    Type: Grant
    Filed: July 1, 2021
    Date of Patent: March 12, 2024
    Assignee: Pfizer inc.
    Inventors: Robert Steven Kania, Padmavani Bezawada, Emma Louise Hawking, Rohit Jaini, Samir Kulkarni, Matthew Nathan O'Brien Laramy, Jonathan Richard Lillis, Suman Luthra, Dafydd Rhys Owen, Klimentina Dimitrova Pencheva, Anil Mahadeo Rane, Matthew Forrest Sammons, Bradley Paul Sullivan, Andrew John Thiel, Martyn David Ticehurst, Jamison Bryce Tuttle, Robert Louis Hoffman
  • Cup
    Patent number: D1025712
    Type: Grant
    Filed: November 19, 2021
    Date of Patent: May 7, 2024
    Assignee: REYNOLDS CONSUMER PRODUCTS LLC
    Inventors: John D. O'Connor, Jonathan Steven Sammon
  • Patent number: D1027564
    Type: Grant
    Filed: June 3, 2021
    Date of Patent: May 21, 2024
    Assignee: REYNOLDS CONSUMER PRODUCTS LLC
    Inventor: Jonathan Steven Sammon